

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 7.27366268 |
| 2 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.63085526 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.87714629 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.87714629 |
| 5 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.37236470 |
| 6 | response to peptidoglycan (GO:0032494) | 5.35330818 |
| 7 | mature B cell differentiation (GO:0002335) | 5.23567403 |
| 8 | positive regulation of B cell differentiation (GO:0045579) | 5.11315275 |
| 9 | negative regulation of interleukin-12 production (GO:0032695) | 4.83551351 |
| 10 | regulation of B cell differentiation (GO:0045577) | 4.73810208 |
| 11 | immunoglobulin mediated immune response (GO:0016064) | 4.71036020 |
| 12 | B cell receptor signaling pathway (GO:0050853) | 4.55270053 |
| 13 | mature B cell differentiation involved in immune response (GO:0002313) | 4.46895524 |
| 14 | megakaryocyte development (GO:0035855) | 4.35117197 |
| 15 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.31068406 |
| 16 | defense response to protozoan (GO:0042832) | 4.30919969 |
| 17 | detection of molecule of bacterial origin (GO:0032490) | 4.24587567 |
| 18 | detection of other organism (GO:0098543) | 4.22493986 |
| 19 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 4.18844475 |
| 20 | regulation of mast cell activation involved in immune response (GO:0033006) | 4.15114438 |
| 21 | detection of bacterium (GO:0016045) | 4.01286363 |
| 22 | positive regulation of leukocyte degranulation (GO:0043302) | 4.01159317 |
| 23 | B cell mediated immunity (GO:0019724) | 4.01088604 |
| 24 | negative regulation of B cell proliferation (GO:0030889) | 3.99899147 |
| 25 | neutrophil activation involved in immune response (GO:0002283) | 3.99162867 |
| 26 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.95511694 |
| 27 | detection of external biotic stimulus (GO:0098581) | 3.95467759 |
| 28 | regulation of hypersensitivity (GO:0002883) | 3.93202798 |
| 29 | cellular response to interferon-beta (GO:0035458) | 3.92178956 |
| 30 | respiratory burst (GO:0045730) | 3.90698689 |
| 31 | negative regulation of cell killing (GO:0031342) | 3.88244857 |
| 32 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.88244857 |
| 33 | response to protozoan (GO:0001562) | 3.82880786 |
| 34 | mast cell activation (GO:0045576) | 3.82331280 |
| 35 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.80595303 |
| 36 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.80176755 |
| 37 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.79048671 |
| 38 | cellular extravasation (GO:0045123) | 3.78985070 |
| 39 | cellular response to exogenous dsRNA (GO:0071360) | 3.77006258 |
| 40 | ribosomal small subunit assembly (GO:0000028) | 3.74463502 |
| 41 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.72852472 |
| 42 | regulation of leukocyte degranulation (GO:0043300) | 3.71687880 |
| 43 | response to interferon-beta (GO:0035456) | 3.69952678 |
| 44 | microglial cell activation (GO:0001774) | 3.68039605 |
| 45 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.67352876 |
| 46 | type I interferon signaling pathway (GO:0060337) | 3.65137625 |
| 47 | cellular response to type I interferon (GO:0071357) | 3.65137625 |
| 48 | heparin metabolic process (GO:0030202) | 3.64801980 |
| 49 | heparin biosynthetic process (GO:0030210) | 3.64801980 |
| 50 | response to type I interferon (GO:0034340) | 3.59554017 |
| 51 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.58309964 |
| 52 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.53948277 |
| 53 | detection of biotic stimulus (GO:0009595) | 3.51589230 |
| 54 | regulation of T cell tolerance induction (GO:0002664) | 3.47335218 |
| 55 | macrophage activation (GO:0042116) | 3.46949786 |
| 56 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.46320070 |
| 57 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.43409893 |
| 58 | positive regulation of interferon-alpha production (GO:0032727) | 3.42650662 |
| 59 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.40174901 |
| 60 | cellular response to zinc ion (GO:0071294) | 3.39807564 |
| 61 | positive regulation of type 2 immune response (GO:0002830) | 3.32777456 |
| 62 | regulation of tolerance induction (GO:0002643) | 3.29317415 |
| 63 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.27413640 |
| 64 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.26007174 |
| 65 | positive regulation by symbiont of host defense response (GO:0052509) | 3.25822333 |
| 66 | modulation by symbiont of host defense response (GO:0052031) | 3.25822333 |
| 67 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.25822333 |
| 68 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.25822333 |
| 69 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.25822333 |
| 70 | modulation by symbiont of host immune response (GO:0052553) | 3.25822333 |
| 71 | myeloid dendritic cell activation (GO:0001773) | 3.25287888 |
| 72 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.25263274 |
| 73 | positive regulation of macrophage differentiation (GO:0045651) | 3.24573782 |
| 74 | mast cell degranulation (GO:0043303) | 3.23965544 |
| 75 | mast cell activation involved in immune response (GO:0002279) | 3.23965544 |
| 76 | regulation of interferon-alpha production (GO:0032647) | 3.23136708 |
| 77 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.22723886 |
| 78 | positive regulation of mast cell degranulation (GO:0043306) | 3.22723886 |
| 79 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.21861375 |
| 80 | neutrophil activation (GO:0042119) | 3.21695008 |
| 81 | cellular response to interferon-gamma (GO:0071346) | 3.21440120 |
| 82 | positive regulation of antigen processing and presentation (GO:0002579) | 3.17226828 |
| 83 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.14865082 |
| 84 | regulation of B cell proliferation (GO:0030888) | 3.14853445 |
| 85 | T-helper 1 type immune response (GO:0042088) | 3.13771957 |
| 86 | response to muramyl dipeptide (GO:0032495) | 3.13670932 |
| 87 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.13193708 |
| 88 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.13123420 |
| 89 | macrophage activation involved in immune response (GO:0002281) | 3.12601366 |
| 90 | signal peptide processing (GO:0006465) | 3.12144470 |
| 91 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.10282319 |
| 92 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.07331633 |
| 93 | myeloid cell activation involved in immune response (GO:0002275) | 3.06801641 |
| 94 | B cell activation involved in immune response (GO:0002312) | 3.06586077 |
| 95 | regulation of mast cell activation (GO:0033003) | 3.05836327 |
| 96 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.05148465 |
| 97 | positive regulation of regulated secretory pathway (GO:1903307) | 3.04620855 |
| 98 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.03723465 |
| 99 | response to host immune response (GO:0052572) | 3.03723465 |
| 100 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.03394104 |
| 101 | regulation of regulated secretory pathway (GO:1903305) | 3.02379697 |
| 102 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.02261054 |
| 103 | lymphoid progenitor cell differentiation (GO:0002320) | 3.01574719 |
| 104 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.00185051 |
| 105 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.99638331 |
| 106 | B cell activation (GO:0042113) | 2.99413255 |
| 107 | response to interferon-gamma (GO:0034341) | 2.98757080 |
| 108 | regulation of B cell activation (GO:0050864) | 2.98722310 |
| 109 | myeloid dendritic cell differentiation (GO:0043011) | 2.98587139 |
| 110 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.97874579 |
| 111 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.97195436 |
| 112 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.96785937 |
| 113 | positive regulation of mast cell activation (GO:0033005) | 2.96158587 |
| 114 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.94856792 |
| 115 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.94532819 |
| 116 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.93222324 |
| 117 | negative regulation of B cell activation (GO:0050869) | 2.93188899 |
| 118 | glucosamine-containing compound catabolic process (GO:1901072) | 2.91850455 |
| 119 | execution phase of apoptosis (GO:0097194) | 2.90322996 |
| 120 | glycosphingolipid catabolic process (GO:0046479) | 2.90268420 |
| 121 | regulation of mast cell degranulation (GO:0043304) | 2.89852944 |
| 122 | granulocyte activation (GO:0036230) | 2.89806174 |
| 123 | regulation of antigen processing and presentation (GO:0002577) | 2.88605147 |
| 124 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.88059246 |
| 125 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.87467305 |
| 126 | regulation of B cell apoptotic process (GO:0002902) | 2.87094002 |
| 127 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.82204564 |
| 128 | positive regulation of B cell mediated immunity (GO:0002714) | 2.82204564 |
| 129 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.81921214 |
| 130 | amino sugar catabolic process (GO:0046348) | 2.81586806 |
| 131 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.80814123 |
| 132 | B cell homeostasis (GO:0001782) | 2.80436542 |
| 133 | response to interferon-alpha (GO:0035455) | 2.78260633 |
| 134 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.78146437 |
| 135 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.77835453 |
| 136 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.77185259 |
| 137 | regulation of type 2 immune response (GO:0002828) | 2.77026844 |
| 138 | lymph node development (GO:0048535) | 2.76029720 |
| 139 | T cell migration (GO:0072678) | 2.75604592 |
| 140 | germinal center formation (GO:0002467) | 2.75447877 |
| 141 | positive regulation of interleukin-12 production (GO:0032735) | 2.75091091 |
| 142 | dendritic cell chemotaxis (GO:0002407) | 2.73912895 |
| 143 | B cell differentiation (GO:0030183) | 2.72129391 |
| 144 | natural killer cell mediated immunity (GO:0002228) | 2.71998381 |
| 145 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.71998381 |
| 146 | regulation of gamma-delta T cell activation (GO:0046643) | 2.71890149 |
| 147 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.71092094 |
| 148 | dendritic cell differentiation (GO:0097028) | 2.70971126 |
| 149 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.69676624 |
| 150 | myeloid leukocyte activation (GO:0002274) | 2.69405825 |
| 151 | positive regulation of interferon-beta production (GO:0032728) | 2.68112837 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.33962989 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.30188165 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.01052451 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.54379027 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.05293778 |
| 6 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.80859038 |
| 7 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.66387503 |
| 8 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.59880079 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.43157649 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.41386218 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.38664630 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.02641394 |
| 13 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.85734929 |
| 14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.81760853 |
| 15 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.66126595 |
| 16 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.62688264 |
| 17 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.59240124 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.50049514 |
| 19 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.49087836 |
| 20 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.45708479 |
| 21 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.44508456 |
| 22 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.31550002 |
| 23 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.19606558 |
| 24 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.19050493 |
| 25 | MYC_22102868_ChIP-Seq_BL_Human | 2.18379696 |
| 26 | MYB_26560356_Chip-Seq_TH2_Human | 2.18180725 |
| 27 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.18152525 |
| 28 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.15290802 |
| 29 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.14711263 |
| 30 | * MYB_26560356_Chip-Seq_TH1_Human | 2.11731541 |
| 31 | GATA1_22025678_ChIP-Seq_K562_Human | 2.11357089 |
| 32 | MAF_26560356_Chip-Seq_TH1_Human | 2.07854671 |
| 33 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.02840818 |
| 34 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.00847235 |
| 35 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.97451515 |
| 36 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.95798889 |
| 37 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.92403323 |
| 38 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.89949083 |
| 39 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.87694085 |
| 40 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87430628 |
| 41 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.87235348 |
| 42 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.85390948 |
| 43 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.83593560 |
| 44 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.81572127 |
| 45 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.80278373 |
| 46 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.72492006 |
| 47 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71289548 |
| 48 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.64884562 |
| 49 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.64843467 |
| 50 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.64368872 |
| 51 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55027468 |
| 52 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.54993609 |
| 53 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.53951331 |
| 54 | SPI1_23127762_ChIP-Seq_K562_Human | 1.50754467 |
| 55 | UTX_26944678_Chip-Seq_JUKART_Human | 1.49200999 |
| 56 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.46168181 |
| 57 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.40799186 |
| 58 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.40755065 |
| 59 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.40404416 |
| 60 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.39835805 |
| 61 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.35305892 |
| 62 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.28235086 |
| 63 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27730459 |
| 64 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.27716267 |
| 65 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.26541191 |
| 66 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.25978809 |
| 67 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.24615739 |
| 68 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.21983083 |
| 69 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.18498978 |
| 70 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.18265305 |
| 71 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.18168608 |
| 72 | GATA3_26560356_Chip-Seq_TH2_Human | 1.17250713 |
| 73 | MAF_26560356_Chip-Seq_TH2_Human | 1.17028847 |
| 74 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.16177526 |
| 75 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15526456 |
| 76 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.11744376 |
| 77 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10024668 |
| 78 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09889585 |
| 79 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09836720 |
| 80 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.09703030 |
| 81 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.07255217 |
| 82 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.06943847 |
| 83 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06378991 |
| 84 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05125605 |
| 85 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04430545 |
| 86 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.03429769 |
| 87 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01363184 |
| 88 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.00834485 |
| 89 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99974421 |
| 90 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.97485972 |
| 91 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.96950834 |
| 92 | GATA1_19941826_ChIP-Seq_K562_Human | 0.94869932 |
| 93 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.94642719 |
| 94 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.94165244 |
| 95 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.92250827 |
| 96 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.92003579 |
| 97 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.91883247 |
| 98 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91071703 |
| 99 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.87964220 |
| 100 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84915779 |
| 101 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84818658 |
| 102 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.79427928 |
| 103 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.77341100 |
| 104 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.74817266 |
| 105 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.74602677 |
| 106 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.70678873 |
| 107 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.70655590 |
| 108 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.70406295 |
| 109 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.70177612 |
| 110 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.69876294 |
| 111 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.69743493 |
| 112 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.69647845 |
| 113 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.69286107 |
| 114 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.68921839 |
| 115 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.68768059 |
| 116 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.68108767 |
| 117 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.68094179 |
| 118 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.68027349 |
| 119 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.66509843 |
| 120 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.66283892 |
| 121 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.66216859 |
| 122 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.65989530 |
| 123 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.65873259 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 6.26736201 |
| 2 | MP0005671_abnormal_response_to | 3.65812823 |
| 3 | MP0001800_abnormal_humoral_immune | 3.60995709 |
| 4 | MP0000685_abnormal_immune_system | 3.59705889 |
| 5 | MP0001790_abnormal_immune_system | 3.33289338 |
| 6 | MP0005387_immune_system_phenotype | 3.33289338 |
| 7 | MP0009785_altered_susceptibility_to | 3.24501024 |
| 8 | MP0002452_abnormal_antigen_presenting | 3.16166477 |
| 9 | MP0002148_abnormal_hypersensitivity_rea | 3.13113487 |
| 10 | MP0003436_decreased_susceptibility_to | 3.03558445 |
| 11 | MP0005000_abnormal_immune_tolerance | 3.01432243 |
| 12 | MP0005025_abnormal_response_to | 2.89904660 |
| 13 | MP0002723_abnormal_immune_serum | 2.85636249 |
| 14 | MP0001819_abnormal_immune_cell | 2.74707398 |
| 15 | MP0002420_abnormal_adaptive_immunity | 2.74674821 |
| 16 | MP0002419_abnormal_innate_immunity | 2.64036358 |
| 17 | MP0002398_abnormal_bone_marrow | 2.46789670 |
| 18 | MP0003303_peritoneal_inflammation | 2.43436402 |
| 19 | MP0005464_abnormal_platelet_physiology | 2.28888871 |
| 20 | MP0000716_abnormal_immune_system | 2.28453684 |
| 21 | MP0001853_heart_inflammation | 2.15832691 |
| 22 | MP0000689_abnormal_spleen_morphology | 2.12454746 |
| 23 | MP0002396_abnormal_hematopoietic_system | 2.06760723 |
| 24 | MP0006082_CNS_inflammation | 1.96434466 |
| 25 | MP0002429_abnormal_blood_cell | 1.94812892 |
| 26 | MP0002166_altered_tumor_susceptibility | 1.94165840 |
| 27 | MP0010155_abnormal_intestine_physiology | 1.91488737 |
| 28 | MP0005397_hematopoietic_system_phenotyp | 1.91398726 |
| 29 | MP0001545_abnormal_hematopoietic_system | 1.91398726 |
| 30 | MP0003763_abnormal_thymus_physiology | 1.89690077 |
| 31 | MP0005174_abnormal_tail_pigmentation | 1.86175782 |
| 32 | MP0002722_abnormal_immune_system | 1.85733697 |
| 33 | MP0004808_abnormal_hematopoietic_stem | 1.82415773 |
| 34 | MP0003806_abnormal_nucleotide_metabolis | 1.80329192 |
| 35 | MP0001845_abnormal_inflammatory_respons | 1.76738725 |
| 36 | MP0003724_increased_susceptibility_to | 1.74842768 |
| 37 | MP0002405_respiratory_system_inflammati | 1.72162244 |
| 38 | MP0009333_abnormal_splenocyte_physiolog | 1.69387957 |
| 39 | MP0002006_tumorigenesis | 1.58309368 |
| 40 | MP0001873_stomach_inflammation | 1.57616181 |
| 41 | MP0005075_abnormal_melanosome_morpholog | 1.52715114 |
| 42 | MP0005310_abnormal_salivary_gland | 1.51192370 |
| 43 | MP0000465_gastrointestinal_hemorrhage | 1.47545929 |
| 44 | MP0008469_abnormal_protein_level | 1.45000063 |
| 45 | MP0000604_amyloidosis | 1.42078436 |
| 46 | MP0006054_spinal_hemorrhage | 1.41338099 |
| 47 | MP0004947_skin_inflammation | 1.37659822 |
| 48 | MP0005451_abnormal_body_composition | 1.35242282 |
| 49 | MP0003866_abnormal_defecation | 1.31059154 |
| 50 | MP0004510_myositis | 1.30295665 |
| 51 | MP0005058_abnormal_lysosome_morphology | 1.29568403 |
| 52 | MP0000490_abnormal_crypts_of | 1.29414534 |
| 53 | MP0008004_abnormal_stomach_pH | 1.28172532 |
| 54 | MP0003690_abnormal_glial_cell | 1.27067823 |
| 55 | MP0009764_decreased_sensitivity_to | 1.26564866 |
| 56 | MP0001533_abnormal_skeleton_physiology | 1.17487761 |
| 57 | MP0003172_abnormal_lysosome_physiology | 1.16812692 |
| 58 | MP0000703_abnormal_thymus_morphology | 1.16430160 |
| 59 | MP0009278_abnormal_bone_marrow | 1.12006148 |
| 60 | MP0002139_abnormal_hepatobiliary_system | 1.06196849 |
| 61 | MP0003300_gastrointestinal_ulcer | 1.05390624 |
| 62 | MP0003828_pulmonary_edema | 1.05337149 |
| 63 | MP0000343_altered_response_to | 1.02878065 |
| 64 | MP0004883_abnormal_blood_vessel | 1.02782274 |
| 65 | MP0002876_abnormal_thyroid_physiology | 1.02637229 |
| 66 | MP0002933_joint_inflammation | 1.02490523 |
| 67 | MP0002095_abnormal_skin_pigmentation | 1.01672367 |
| 68 | MP0000015_abnormal_ear_pigmentation | 0.98779749 |
| 69 | MP0010094_abnormal_chromosome_stability | 0.97144187 |
| 70 | MP0002019_abnormal_tumor_incidence | 0.94856916 |
| 71 | MP0000858_altered_metastatic_potential | 0.92296288 |
| 72 | MP0005167_abnormal_blood-brain_barrier | 0.91985733 |
| 73 | MP0000920_abnormal_myelination | 0.90665740 |
| 74 | MP0001986_abnormal_taste_sensitivity | 0.90524006 |
| 75 | MP0003943_abnormal_hepatobiliary_system | 0.90358748 |
| 76 | MP0010307_abnormal_tumor_latency | 0.89858812 |
| 77 | MP0005164_abnormal_response_to | 0.89729674 |
| 78 | MP0001851_eye_inflammation | 0.88057048 |
| 79 | MP0008260_abnormal_autophagy | 0.85565132 |
| 80 | MP0002277_abnormal_respiratory_mucosa | 0.85137746 |
| 81 | MP0003075_altered_response_to | 0.84482071 |
| 82 | MP0009763_increased_sensitivity_to | 0.83578567 |
| 83 | MP0005390_skeleton_phenotype | 0.80682531 |
| 84 | MP0003191_abnormal_cellular_cholesterol | 0.77884122 |
| 85 | MP0001348_abnormal_lacrimal_gland | 0.77240650 |
| 86 | MP0005165_increased_susceptibility_to | 0.76657178 |
| 87 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.75101482 |
| 88 | MP0008057_abnormal_DNA_replication | 0.74003990 |
| 89 | MP0001542_abnormal_bone_strength | 0.71901142 |
| 90 | MP0003795_abnormal_bone_structure | 0.71513162 |
| 91 | MP0005084_abnormal_gallbladder_morpholo | 0.70794699 |
| 92 | MP0002138_abnormal_hepatobiliary_system | 0.69955417 |
| 93 | MP0000681_abnormal_thyroid_gland | 0.69222690 |
| 94 | MP0003186_abnormal_redox_activity | 0.67663250 |
| 95 | MP0005166_decreased_susceptibility_to | 0.67568245 |
| 96 | MP0003448_altered_tumor_morphology | 0.67332920 |
| 97 | MP0001663_abnormal_digestive_system | 0.66171936 |
| 98 | MP0001879_abnormal_lymphatic_vessel | 0.66121403 |
| 99 | MP0005319_abnormal_enzyme/_coenzyme | 0.65790816 |
| 100 | MP0004147_increased_porphyrin_level | 0.65470288 |
| 101 | MP0002132_abnormal_respiratory_system | 0.65360808 |
| 102 | MP0008058_abnormal_DNA_repair | 0.65045080 |
| 103 | MP0009765_abnormal_xenobiotic_induced | 0.64926892 |
| 104 | MP0009379_abnormal_foot_pigmentation | 0.64726239 |
| 105 | MP0000249_abnormal_blood_vessel | 0.63628863 |
| 106 | MP0002693_abnormal_pancreas_physiology | 0.62479059 |
| 107 | MP0009840_abnormal_foam_cell | 0.62295157 |
| 108 | MP0003453_abnormal_keratinocyte_physiol | 0.62289340 |
| 109 | MP0003656_abnormal_erythrocyte_physiolo | 0.62091919 |
| 110 | MP0002332_abnormal_exercise_endurance | 0.60933968 |
| 111 | MP0003183_abnormal_peptide_metabolism | 0.59244115 |
| 112 | MP0003693_abnormal_embryo_hatching | 0.59236615 |
| 113 | MP0005647_abnormal_sex_gland | 0.58698214 |
| 114 | MP0000598_abnormal_liver_morphology | 0.57793831 |
| 115 | MP0008007_abnormal_cellular_replicative | 0.57605613 |
| 116 | MP0008874_decreased_physiological_sensi | 0.56983056 |
| 117 | MP0000569_abnormal_digit_pigmentation | 0.56954541 |
| 118 | MP0005365_abnormal_bile_salt | 0.56252578 |
| 119 | MP0001764_abnormal_homeostasis | 0.53551367 |
| 120 | MP0005535_abnormal_body_temperature | 0.52943320 |
| 121 | MP0000477_abnormal_intestine_morphology | 0.52850085 |
| 122 | MP0002136_abnormal_kidney_physiology | 0.52266421 |
| 123 | MP0002928_abnormal_bile_duct | 0.52195319 |
| 124 | MP0000371_diluted_coat_color | 0.52173220 |
| 125 | MP0002998_abnormal_bone_remodeling | 0.52058052 |
| 126 | MP0000609_abnormal_liver_physiology | 0.48121237 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 6.14321620 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.61587847 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.61587847 |
| 4 | Abnormality of glycolipid metabolism (HP:0010969) | 5.61587847 |
| 5 | Recurrent abscess formation (HP:0002722) | 5.59831342 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 5.44384692 |
| 7 | Recurrent bronchitis (HP:0002837) | 5.21627875 |
| 8 | Cellulitis (HP:0100658) | 4.64145552 |
| 9 | Chronic otitis media (HP:0000389) | 4.58033645 |
| 10 | Eczematoid dermatitis (HP:0000976) | 4.52619019 |
| 11 | Abnormality of B cell number (HP:0010975) | 4.39208919 |
| 12 | B lymphocytopenia (HP:0010976) | 4.39208919 |
| 13 | Systemic lupus erythematosus (HP:0002725) | 4.33029095 |
| 14 | IgM deficiency (HP:0002850) | 4.22396503 |
| 15 | Recurrent viral infections (HP:0004429) | 4.18412458 |
| 16 | Colitis (HP:0002583) | 4.15610479 |
| 17 | Gastrointestinal stroma tumor (HP:0100723) | 4.02551154 |
| 18 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.97424468 |
| 19 | Meningitis (HP:0001287) | 3.95061249 |
| 20 | Thrombocytosis (HP:0001894) | 3.89879844 |
| 21 | Stomatitis (HP:0010280) | 3.84330410 |
| 22 | Myositis (HP:0100614) | 3.83788374 |
| 23 | Recurrent skin infections (HP:0001581) | 3.67436224 |
| 24 | Recurrent pneumonia (HP:0006532) | 3.66011091 |
| 25 | Inflammation of the large intestine (HP:0002037) | 3.65783572 |
| 26 | Dysostosis multiplex (HP:0000943) | 3.59585095 |
| 27 | Mediastinal lymphadenopathy (HP:0100721) | 3.55451189 |
| 28 | Amyloidosis (HP:0011034) | 3.53465673 |
| 29 | Recurrent sinusitis (HP:0011108) | 3.51435345 |
| 30 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.47977888 |
| 31 | Gastrointestinal inflammation (HP:0004386) | 3.44976670 |
| 32 | Vasculitis (HP:0002633) | 3.40866630 |
| 33 | Recurrent fungal infections (HP:0002841) | 3.35643958 |
| 34 | Recurrent lower respiratory tract infections (HP:0002783) | 3.24444141 |
| 35 | Abnormality of macrophages (HP:0004311) | 3.22091603 |
| 36 | Spontaneous hematomas (HP:0007420) | 3.21213306 |
| 37 | Panhypogammaglobulinemia (HP:0003139) | 3.20243544 |
| 38 | Prolonged bleeding time (HP:0003010) | 3.03568976 |
| 39 | Osteomyelitis (HP:0002754) | 3.02910205 |
| 40 | Mutism (HP:0002300) | 3.02563029 |
| 41 | Petechiae (HP:0000967) | 3.02552362 |
| 42 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.01198071 |
| 43 | Bronchitis (HP:0012387) | 2.99150823 |
| 44 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.95753119 |
| 45 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.94019611 |
| 46 | Chronic obstructive pulmonary disease (HP:0006510) | 2.91874357 |
| 47 | Obstructive lung disease (HP:0006536) | 2.91874357 |
| 48 | Interstitial pulmonary disease (HP:0006530) | 2.89668065 |
| 49 | Verrucae (HP:0200043) | 2.82777753 |
| 50 | Papilloma (HP:0012740) | 2.82777753 |
| 51 | Chronic sinusitis (HP:0011109) | 2.79863397 |
| 52 | Abnormality of T cell physiology (HP:0011840) | 2.79047959 |
| 53 | Gingivitis (HP:0000230) | 2.77401409 |
| 54 | Recurrent cutaneous fungal infections (HP:0011370) | 2.77291064 |
| 55 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.77291064 |
| 56 | Arterial thrombosis (HP:0004420) | 2.76032281 |
| 57 | Increased cerebral lipofuscin (HP:0011813) | 2.73983069 |
| 58 | Lymphopenia (HP:0001888) | 2.67702049 |
| 59 | Aplastic anemia (HP:0001915) | 2.66763359 |
| 60 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.66011526 |
| 61 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.66011526 |
| 62 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.66011526 |
| 63 | Poikiloderma (HP:0001029) | 2.64979157 |
| 64 | Gastrointestinal infarctions (HP:0005244) | 2.64268642 |
| 65 | Acute lymphatic leukemia (HP:0006721) | 2.61204158 |
| 66 | Optic neuritis (HP:0100653) | 2.60600397 |
| 67 | Retrobulbar optic neuritis (HP:0100654) | 2.60600397 |
| 68 | Emphysema (HP:0002097) | 2.60447960 |
| 69 | Chest pain (HP:0100749) | 2.58818610 |
| 70 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.57807802 |
| 71 | Orchitis (HP:0100796) | 2.56356599 |
| 72 | Loss of speech (HP:0002371) | 2.55988912 |
| 73 | Abnormality of T cells (HP:0002843) | 2.55907191 |
| 74 | Nasal polyposis (HP:0100582) | 2.54133308 |
| 75 | Keratoconjunctivitis (HP:0001096) | 2.53011077 |
| 76 | IgG deficiency (HP:0004315) | 2.52035836 |
| 77 | Mucopolysacchariduria (HP:0008155) | 2.50544620 |
| 78 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.50544620 |
| 79 | Hepatosplenomegaly (HP:0001433) | 2.48376018 |
| 80 | Epistaxis (HP:0000421) | 2.47862946 |
| 81 | Glomerulonephritis (HP:0000099) | 2.47348343 |
| 82 | Axonal loss (HP:0003447) | 2.46385553 |
| 83 | Vacuolated lymphocytes (HP:0001922) | 2.45988771 |
| 84 | Increased serum ferritin (HP:0003281) | 2.45948513 |
| 85 | Impaired platelet aggregation (HP:0003540) | 2.45045955 |
| 86 | Abnormal platelet function (HP:0011869) | 2.45045955 |
| 87 | Increased IgE level (HP:0003212) | 2.41537864 |
| 88 | Agnosia (HP:0010524) | 2.40542585 |
| 89 | Gangrene (HP:0100758) | 2.39916011 |
| 90 | Pulmonary embolism (HP:0002204) | 2.36640324 |
| 91 | Abnormality of the prostate (HP:0008775) | 2.36575381 |
| 92 | Encephalitis (HP:0002383) | 2.34742009 |
| 93 | Chronic diarrhea (HP:0002028) | 2.34571196 |
| 94 | Abnormality of the pleura (HP:0002103) | 2.33943945 |
| 95 | Skin rash (HP:0000988) | 2.33695453 |
| 96 | Abnormality of the nasal mucosa (HP:0000433) | 2.33563527 |
| 97 | Polyneuropathy (HP:0001271) | 2.32429936 |
| 98 | Reduced antithrombin III activity (HP:0001976) | 2.30951222 |
| 99 | Lymphoma (HP:0002665) | 2.29861687 |
| 100 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.29697470 |
| 101 | Cutaneous melanoma (HP:0012056) | 2.29624803 |
| 102 | Entropion (HP:0000621) | 2.28685321 |
| 103 | IgA deficiency (HP:0002720) | 2.27780211 |
| 104 | Autoimmune hemolytic anemia (HP:0001890) | 2.27685915 |
| 105 | Autoimmune thrombocytopenia (HP:0001973) | 2.24845667 |
| 106 | Urticaria (HP:0001025) | 2.23427252 |
| 107 | Sepsis (HP:0100806) | 2.23293978 |
| 108 | Pulmonary infiltrates (HP:0002113) | 2.22353819 |
| 109 | Neutropenia (HP:0001875) | 2.21467341 |
| 110 | Diminished motivation (HP:0000745) | 2.19314922 |
| 111 | Leukocytosis (HP:0001974) | 2.15378306 |
| 112 | Gingival bleeding (HP:0000225) | 2.15325641 |
| 113 | Pustule (HP:0200039) | 2.14644834 |
| 114 | Increased IgM level (HP:0003496) | 2.13925445 |
| 115 | Abnormality of iron homeostasis (HP:0011031) | 2.13390284 |
| 116 | Abnormality of T cell number (HP:0011839) | 2.12553596 |
| 117 | Restrictive lung disease (HP:0002091) | 2.11228549 |
| 118 | Papilledema (HP:0001085) | 2.10364898 |
| 119 | Apathy (HP:0000741) | 2.09328263 |
| 120 | Exertional dyspnea (HP:0002875) | 2.09033772 |
| 121 | Progressive neurologic deterioration (HP:0002344) | 2.08355685 |
| 122 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.08325521 |
| 123 | Upper motor neuron abnormality (HP:0002127) | 2.07644487 |
| 124 | Inappropriate behavior (HP:0000719) | 2.07290238 |
| 125 | Amaurosis fugax (HP:0100576) | 2.06932335 |
| 126 | Hypergammaglobulinemia (HP:0010702) | 2.05753397 |
| 127 | Memory impairment (HP:0002354) | 2.04180763 |
| 128 | T lymphocytopenia (HP:0005403) | 2.03357265 |
| 129 | Glomerulopathy (HP:0100820) | 2.03182547 |
| 130 | Leukopenia (HP:0001882) | 2.02378022 |
| 131 | Skin ulcer (HP:0200042) | 2.01910408 |
| 132 | Microcytic anemia (HP:0001935) | 2.01346908 |
| 133 | Anorexia (HP:0002039) | 1.99867058 |
| 134 | Hematochezia (HP:0002573) | 1.98705465 |
| 135 | Abnormality of complement system (HP:0005339) | 1.98560911 |
| 136 | Purpura (HP:0000979) | 1.97946471 |
| 137 | Thoracic kyphosis (HP:0002942) | 1.96520616 |
| 138 | Complement deficiency (HP:0004431) | 1.96453056 |
| 139 | Vertigo (HP:0002321) | 1.96130758 |
| 140 | Keratoconjunctivitis sicca (HP:0001097) | 1.95713721 |
| 141 | Basal ganglia calcification (HP:0002135) | 1.93100876 |
| 142 | Disinhibition (HP:0000734) | 1.91621892 |
| 143 | Premature loss of primary teeth (HP:0006323) | 1.91540394 |
| 144 | Recurrent otitis media (HP:0000403) | 1.91414510 |
| 145 | Neuronal loss in central nervous system (HP:0002529) | 1.91387125 |
| 146 | Hemoptysis (HP:0002105) | 1.89845944 |
| 147 | Abnormal number of erythroid precursors (HP:0012131) | 1.89529122 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K13 | 4.49504520 |
| 2 | MAP4K1 | 4.16101428 |
| 3 | MAP3K14 | 3.63578594 |
| 4 | KIT | 3.20777051 |
| 5 | PKN2 | 2.99800081 |
| 6 | BMPR2 | 2.87476455 |
| 7 | TRIB3 | 2.78778463 |
| 8 | TBK1 | 2.66478401 |
| 9 | TNIK | 2.61687449 |
| 10 | CSF1R | 2.54386353 |
| 11 | IRAK4 | 2.44810874 |
| 12 | BLK | 2.22321990 |
| 13 | RIPK4 | 2.15294028 |
| 14 | TYK2 | 2.13913703 |
| 15 | TEC | 2.07730111 |
| 16 | SYK | 2.07508956 |
| 17 | BTK | 2.05884569 |
| 18 | NME2 | 2.01187702 |
| 19 | ERN1 | 1.91286484 |
| 20 | FGR | 1.83546605 |
| 21 | FLT3 | 1.78136874 |
| 22 | STK4 | 1.77739052 |
| 23 | IKBKB | 1.77269137 |
| 24 | SIK3 | 1.66973524 |
| 25 | LRRK2 | 1.60459998 |
| 26 | JAK3 | 1.59929294 |
| 27 | SRPK1 | 1.59300308 |
| 28 | PRPF4B | 1.58725700 |
| 29 | MAP3K11 | 1.56655050 |
| 30 | IKBKE | 1.55262178 |
| 31 | MATK | 1.53884552 |
| 32 | TNK2 | 1.51035493 |
| 33 | MAP3K3 | 1.50773958 |
| 34 | TAOK3 | 1.44205711 |
| 35 | ZAP70 | 1.41225726 |
| 36 | TAOK2 | 1.39258968 |
| 37 | LYN | 1.32717932 |
| 38 | TAOK1 | 1.32619819 |
| 39 | TGFBR2 | 1.28801786 |
| 40 | MAP3K12 | 1.25886578 |
| 41 | FES | 1.24754420 |
| 42 | STK16 | 1.23903939 |
| 43 | PIM2 | 1.23772506 |
| 44 | MAP2K3 | 1.17521907 |
| 45 | GRK6 | 1.15139259 |
| 46 | MOS | 1.12393999 |
| 47 | CHUK | 1.11972310 |
| 48 | CDK6 | 1.09300696 |
| 49 | CDK4 | 1.03409945 |
| 50 | SIK2 | 0.99643810 |
| 51 | LCK | 0.97998096 |
| 52 | CLK1 | 0.97952025 |
| 53 | TESK2 | 0.96313932 |
| 54 | CDK19 | 0.95394547 |
| 55 | TXK | 0.94168531 |
| 56 | JAK1 | 0.93444231 |
| 57 | MAP3K1 | 0.92362154 |
| 58 | CAMKK2 | 0.91308337 |
| 59 | IRAK3 | 0.87475960 |
| 60 | MAP2K7 | 0.85813405 |
| 61 | PIM1 | 0.84682981 |
| 62 | PIK3CG | 0.82970085 |
| 63 | HCK | 0.81805745 |
| 64 | CSK | 0.81428086 |
| 65 | ABL2 | 0.81275949 |
| 66 | STK10 | 0.80167914 |
| 67 | STK38 | 0.79659889 |
| 68 | ILK | 0.78585169 |
| 69 | EIF2AK3 | 0.76294163 |
| 70 | ITK | 0.75577352 |
| 71 | NUAK1 | 0.74804727 |
| 72 | CDC42BPA | 0.74315870 |
| 73 | MKNK2 | 0.69553621 |
| 74 | PRKCQ | 0.67056354 |
| 75 | STK24 | 0.65946474 |
| 76 | PDPK1 | 0.64220820 |
| 77 | CAMKK1 | 0.63929906 |
| 78 | NEK9 | 0.61826548 |
| 79 | MUSK | 0.61605805 |
| 80 | BCKDK | 0.60561802 |
| 81 | MAPK12 | 0.59608357 |
| 82 | MAP2K6 | 0.59071081 |
| 83 | MAP3K5 | 0.58827465 |
| 84 | MAPK7 | 0.58670059 |
| 85 | IRAK2 | 0.57669519 |
| 86 | ADRBK2 | 0.56315461 |
| 87 | GRK1 | 0.56075150 |
| 88 | YES1 | 0.54597197 |
| 89 | DDR2 | 0.54558628 |
| 90 | ACVR1B | 0.54392365 |
| 91 | RPS6KA4 | 0.54329765 |
| 92 | RAF1 | 0.53976048 |
| 93 | MKNK1 | 0.53708746 |
| 94 | FYN | 0.52894275 |
| 95 | VRK1 | 0.52009762 |
| 96 | IRAK1 | 0.51622232 |
| 97 | NLK | 0.49267150 |
| 98 | TIE1 | 0.47748510 |
| 99 | ARAF | 0.47546232 |
| 100 | DYRK3 | 0.46336506 |
| 101 | MAPK4 | 0.44471567 |
| 102 | MAP3K7 | 0.44300633 |
| 103 | CHEK2 | 0.40127109 |
| 104 | MAP3K10 | 0.40076479 |
| 105 | TRPM7 | 0.39887916 |
| 106 | EGFR | 0.39118268 |
| 107 | KDR | 0.38479112 |
| 108 | DAPK3 | 0.38446762 |
| 109 | MARK2 | 0.38063173 |
| 110 | MAP3K6 | 0.37893003 |
| 111 | RPS6KL1 | 0.37849372 |
| 112 | RPS6KC1 | 0.37849372 |
| 113 | EEF2K | 0.37755453 |
| 114 | MAPKAPK2 | 0.36546259 |
| 115 | PRKCD | 0.35028930 |
| 116 | EIF2AK2 | 0.34656175 |
| 117 | HIPK2 | 0.34656095 |
| 118 | PDK1 | 0.33914382 |
| 119 | ABL1 | 0.32754885 |
| 120 | SIK1 | 0.32185728 |
| 121 | CCNB1 | 0.31486727 |
| 122 | RPS6KA6 | 0.31002461 |
| 123 | RIPK1 | 0.30871914 |
| 124 | JAK2 | 0.30826098 |
| 125 | PAK4 | 0.30480499 |
| 126 | TGFBR1 | 0.30366568 |
| 127 | MARK3 | 0.30024200 |
| 128 | KSR2 | 0.29898707 |
| 129 | EPHB1 | 0.29856406 |
| 130 | MST4 | 0.29448184 |
| 131 | DAPK2 | 0.28520283 |
| 132 | CAMK1D | 0.28274834 |
| 133 | ATR | 0.27514641 |
| 134 | IGF1R | 0.26601426 |
| 135 | MYLK | 0.26572341 |
| 136 | PTK6 | 0.25819051 |
| 137 | PRKG2 | 0.23897489 |
| 138 | FGFR4 | 0.23656743 |
| 139 | GRK7 | 0.22551883 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.59436607 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 3.46580805 |
| 3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.20030351 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.71331911 |
| 5 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.40913273 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.34995019 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.28882734 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.18097379 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.15751151 |
| 10 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.12357226 |
| 11 | Allograft rejection_Homo sapiens_hsa05330 | 2.09954162 |
| 12 | Measles_Homo sapiens_hsa05162 | 1.94879297 |
| 13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.94038852 |
| 14 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.89975654 |
| 15 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.86585263 |
| 16 | DNA replication_Homo sapiens_hsa03030 | 1.84293704 |
| 17 | Protein export_Homo sapiens_hsa03060 | 1.78773662 |
| 18 | Pertussis_Homo sapiens_hsa05133 | 1.77269278 |
| 19 | Asthma_Homo sapiens_hsa05310 | 1.76247746 |
| 20 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.68373822 |
| 21 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.66594239 |
| 22 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.61169631 |
| 23 | Ribosome_Homo sapiens_hsa03010 | 1.59299476 |
| 24 | Influenza A_Homo sapiens_hsa05164 | 1.56116394 |
| 25 | Other glycan degradation_Homo sapiens_hsa00511 | 1.54623965 |
| 26 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.54591689 |
| 27 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.53659321 |
| 28 | Tuberculosis_Homo sapiens_hsa05152 | 1.52373277 |
| 29 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.52281107 |
| 30 | Base excision repair_Homo sapiens_hsa03410 | 1.51344058 |
| 31 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.49628355 |
| 32 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.48763609 |
| 33 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.47606165 |
| 34 | Legionellosis_Homo sapiens_hsa05134 | 1.45396811 |
| 35 | Shigellosis_Homo sapiens_hsa05131 | 1.43780880 |
| 36 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.42045856 |
| 37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.38552913 |
| 38 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.38459387 |
| 39 | Mismatch repair_Homo sapiens_hsa03430 | 1.37365523 |
| 40 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.31999712 |
| 41 | Malaria_Homo sapiens_hsa05144 | 1.30957912 |
| 42 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.29090354 |
| 43 | Platelet activation_Homo sapiens_hsa04611 | 1.28617262 |
| 44 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.25874702 |
| 45 | Homologous recombination_Homo sapiens_hsa03440 | 1.24016481 |
| 46 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.22982626 |
| 47 | Hepatitis B_Homo sapiens_hsa05161 | 1.19383052 |
| 48 | Apoptosis_Homo sapiens_hsa04210 | 1.18627246 |
| 49 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.18107004 |
| 50 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.14658387 |
| 51 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.12277934 |
| 52 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.09914265 |
| 53 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.03454694 |
| 54 | Viral myocarditis_Homo sapiens_hsa05416 | 0.96144492 |
| 55 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.94608486 |
| 56 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.94119256 |
| 57 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.92610038 |
| 58 | Hepatitis C_Homo sapiens_hsa05160 | 0.90276498 |
| 59 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.90203300 |
| 60 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.90175063 |
| 61 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.88989012 |
| 62 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.85534187 |
| 63 | Salmonella infection_Homo sapiens_hsa05132 | 0.83117204 |
| 64 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.83101931 |
| 65 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.79233135 |
| 66 | Lysosome_Homo sapiens_hsa04142 | 0.78747078 |
| 67 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.77974341 |
| 68 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.76492670 |
| 69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.73553844 |
| 70 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.69899612 |
| 71 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.67306474 |
| 72 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.66511764 |
| 73 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.66262333 |
| 74 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.64227083 |
| 75 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.63641274 |
| 76 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.59338556 |
| 77 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.57644021 |
| 78 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.57447259 |
| 79 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.57311072 |
| 80 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.53086042 |
| 81 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.52134411 |
| 82 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.51901367 |
| 83 | Amoebiasis_Homo sapiens_hsa05146 | 0.49459462 |
| 84 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.49145224 |
| 85 | HTLV-I infection_Homo sapiens_hsa05166 | 0.48773508 |
| 86 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.44921286 |
| 87 | Phagosome_Homo sapiens_hsa04145 | 0.44763255 |
| 88 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.42929633 |
| 89 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.41918657 |
| 90 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.41202021 |
| 91 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.39792083 |
| 92 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.39572201 |
| 93 | Spliceosome_Homo sapiens_hsa03040 | 0.39059217 |
| 94 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.38560186 |
| 95 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.36463234 |
| 96 | Endocytosis_Homo sapiens_hsa04144 | 0.36003934 |
| 97 | Bladder cancer_Homo sapiens_hsa05219 | 0.35174576 |
| 98 | Prion diseases_Homo sapiens_hsa05020 | 0.33152837 |
| 99 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.31775416 |
| 100 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.30094409 |
| 101 | Colorectal cancer_Homo sapiens_hsa05210 | 0.29157279 |
| 102 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.28288209 |
| 103 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.24738863 |
| 104 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24381807 |
| 105 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.24015937 |
| 106 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.23365140 |
| 107 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.22929726 |
| 108 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.22007780 |
| 109 | RNA degradation_Homo sapiens_hsa03018 | 0.20928662 |
| 110 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.20399023 |
| 111 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.20035955 |
| 112 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.18991306 |
| 113 | Cell cycle_Homo sapiens_hsa04110 | 0.18287659 |
| 114 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.18105870 |
| 115 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.16934467 |
| 116 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.16530704 |
| 117 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.13692807 |
| 118 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.12956410 |
| 119 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.11876261 |
| 120 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.11563936 |
| 121 | Mineral absorption_Homo sapiens_hsa04978 | 0.11516060 |
| 122 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.08938558 |
| 123 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.06099536 |
| 124 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.03979414 |

